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Anatomical, functional and metabolic imaging
of radiation-induced lung injury using
hyperpolarized MRI
Giles Santyra,b,c,d*, Matthew Foxe, Kundan Thinda,b, Elaine Hegartya,
Alexei Ouriadove, Michael Jensenf, Timothy J. Scholla,b,
Jacob Van Dykb,f,g and Eugene Wongb,f,g
MRI of hyperpolarized 129Xe gas and 13C-enriched substrates (e.g. pyruvate) presents an unprecedented opportunity to
map anatomical, functional and metabolic changes associated with lung injury. In particular, inhaled hyperpolarized
129Xe gas is exquisitely sensitive to changes in alveolar microanatomy and function accompanying lung inﬂammation
through decreases in the apparent diffusion coefﬁcient (ADC) of alveolar gas and increases in the transfer time (Ttr) of
xenon exchange from the gas and into the dissolved phase in the lung. Furthermore, metabolic changes associated
with hypoxia arising from lung injury may be reﬂected by increases in lactate-to-pyruvate signal ratio obtained by
magnetic resonance spectroscopic imaging following injection of hyperpolarized [1-13C]pyruvate. In this work, the
application of hyperpolarized 129Xe and 13C MRI to radiation-induced lung injury (RILI) is reviewed and results of
ADC, Ttr and lactate-to-pyruvate signal ratio changes in a rat model of RILI are summarized. These results are consistent
with conventional functional (i.e. blood gases) and histological (i.e. tissue density) changes, and correlate signiﬁcantly
with inﬂammatory cell counts (i.e. macrophages). Hyperpolarized MRI may provide an earlier indication of lung injury
associated with radiotherapy of thoracic tumors, potentially allowing adjustment of treatment before the onset of
severe complications and irreversible ﬁbrosis. Copyright © 2014 John Wiley & Sons, Ltd.
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INTRODUCTION
Lung cancer is the leading cause of cancer death in the world.
80% of all lung cancers are non-small cell lung carcinoma (NSCLC),
which are often treated with thoracic radiotherapy (RT); however,
the lung is a very radiosensitive organ and radiation-induced lung
injury (RILI) is a common side effect. The incidence of RILI is
reported to be 37%, and of this population 20% are diagnosed
with moderate to severe RILI (1). Coughing, fever and dyspnea
have also been reported in 5–50% of the RILI population (2). RILI
can lead to temporary or permanent loss of lung function and in
extreme cases death (3).
Clinical assessment and management of RILI utilizes both
pulmonary function tests (PFTs) (e.g. spirometry, blood gases)
and imaging techniques. Persistence of hypoxia as measured by
the partial pressure of oxygen in arterial blood (paO2) has been
reported post radiation therapy (4,5), and recent studies suggest
that it may further exacerbate lung injury (2). However, PFTs are
whole-lung measurements and cannot identify regional deﬁcien-
cies in lung function, which presumably reduces the sensitivity of
PFTs to early injury. Imaging of RILI is typically performed using
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planar X-ray and computed tomography (CT). Although CT
changes have been observed before the onset of clinical RILI (6),
these anatomical changes (e.g. lung density) often do not occur
before clinical symptoms manifest (7,8). In a previous study, RILI
was detected using CT in roughly 75% of patients undergoing
RT, but not detected earlier than fourweeks post RT (9). CT imaging
of late-stage RILI is currently the gold standard for discerning
ﬁbrosis from lung tumor recurrence; however, it is often too late
(several months) to effect any change in therapy to mitigate RILI.
An imaging method sensitive to early (weeks) changes associated
with RILI (i.e. radiation pneumonitis, RP) would be valuable to
identify radiosensitive individuals and adjust therapy accordingly.
X-ray imaging methods are insensitive to functional changes
associated with early RILI such as deﬁcits in gas exchange,
perfusion and ventilation, which are expected to occur well
before anatomical changes. For this reason, nuclear medicine
imaging techniques such as single-photon emission computed
tomography (SPECT) and positron emission tomography (PET)
can be used when functional lung information such as perfusion
is required (10). Functional imaging with SPECT can provide
ventilation and perfusion maps of the lung post injection of
technetium-99m (11,12). Studies have demonstrated a dose-
dependent reduction in perfusion and ventilation at 3–4 months
post radiation therapy (13,14). However, correlations between
these metrics and whole-lung function assessed by pulmonary
function testing (i.e. forced expiratory volume in 1 s and diffusing
capacity for carbon monoxide) are weak and additional work is
required to assess regional injury (10). Additionally, SPECT
imaging is limited in spatial resolution, lacks speciﬁcity and
provides ~3mSv of extra whole-body radiation dose to the
patient (15), which is approximately three times the annual
background dose (~1mSv) and 60% of the annual radiation
worker limit(~5mSv). PET imaging with ﬂuorodeoxyglucose (18F-
FDG) has shown increased uptake of 18F-FDG associated with RILI
in lung cancer patients (16); however, the technique is heavily
dependent on tissue uptake of 18F-FDG and is susceptible to a
high false positive rate (17). In particular, high uptake of 18F-FDG
is associated with both inﬂammation and tumor growth, and no
clear separation of RILI and cancer has been demonstrated
(18,19). As with SPECT, PET requires an acquisition time of
approximately an hour and also incurs additional radiation dose
to the patient (~15% of the annual radiation worker limit).
In contrast to X-ray and nuclear medicine imaging methods,
MRI provides an approach for probing lung anatomy and
function without the use of ionizing radiation, which may be
particularly well suited for tracking the progression and
regression of the early stage of RILI. Conventional MRI (i.e.
proton) approaches aimed at detection of RILI have been
performed previously through the measurement of regional
perfusion (20) and the T2 relaxation times of lung tissues (21).
However, proton MRI is challenging in the lung due to low
proton signal, as it contains only approximately 20% soft tissue.
This low signal is further diminished by the presence of
microscopic magnetic ﬁeld non-uniformities arising from
susceptibility differences at the gas/tissue interface. Further-
more, respiratory motion can be problematic, leading to image
blurring and other artifacts.
The issue of low MRI signal in the lung has recently been
addressed by the advent of spin exchange optical pumping (i.e.
hyperpolarization) techniques, which can boost the signal of
certain inhaled noble gases (3He and 129Xe) by up to ﬁve orders
of magnitude (22). High spatial resolution spectroscopic imaging
can be achieved with hyperpolarized gas MRI, and it provides a
wide palette of anatomical and functional biomarkers, which can
potentially map RILI progression and treatment response
including ventilation (23), perfusion (24), and gas exchange (25).
In addition, a truly unique morphological lung measurement is
possible using hyperpolarized gas MRI, namely the apparent
diffusion coefﬁcient (ADC), a surrogate for alveolar size. Some of
these measures have already been investigated in patients with
chronic obstructive pulmonary disease (COPD) (26–28), asthma
(29) and cystic ﬁbrosis (30,31), as well as in animal models of lung
disease (20,24,25,27,32–36). More recently, 13C has been added to
the family of hyperpolarized nuclei available for use with MRI (37).
The polarization of 13C nuclei can be greatly enhanced in the solid
state using dynamic nuclear polarization (DNP), in which certain
13C-enriched endogenous compounds may be prepared with
liquid-state polarizations exceeding 20% as injectable probes of
cellular metabolism. In vivo MR spectroscopic imaging of the
metabolites of hyperpolarized contrast agents such as [1-13C]pyru-
vate and [1-13C-]lactate have been used to differentiate tissue
undergoing anaerobic glycolysis, most notably associated with
cancer and hypoxia (38–41).
This article reviews the current state of hyperpolarized MRI in the
context of a mechanistic picture of RILI pathogenesis. Several impor-
tant experimental hyperpolarized MRI approaches are presented,
and results of anatomical and functional hyperpolarized 129Xe MRI
of RILI are summarized, including ADC mapping, morphometry
and gas exchangemeasurement using a whole-thorax model of RILI
in the rat. Next, metabolic MRI studies using hyperpolarized [113C]
pyruvate for early detection of RILI in a rat model are described.
Finally, limitations and future directions of hyperpolarized MRI are
presented, and extensions to clinical applications are discussed.
Pathogenesis of RILI
Following acute radiation damage, the inﬂammatory cascade
associated with RILI (Fig. 1) consists of two main phases: (i) an
early phase characterized by RP and (ii) a later phase
characterized by tissue remodeling and ﬁbrosis (42,43), though
one can occur without the other. The RP stage, typically lasting
days to several weeks, is initiated by an overwhelming
inﬂammatory response believed to be triggered by cytokines
(e.g. interleukin 6, tumor necrosis factor alpha) released by acti-
vated resident leukocytes (i.e.macrophages), signaling migrating
leukocytes (e.g. macrophages and neutrophils) to adhere to and
penetrate the injured epithelial and endothelial layers. If injury to
the alveolar epithelium is signiﬁcant and/or unrepaired, chronic
ﬁbrosis will result (months). This can lead to progressive lung
function loss and ultimate organ failure, affecting about 50% of
individuals with severe lung injury. The occurrence of RP is
characterized by the onset of inﬂammation, which is highly
dependent on the release of inﬂammatory cytokines (44).
Immunohistochemical analysis of RP in animal models reveals
underlying cellular changes including increases in alveolar
macrophages, inﬂammatory cytokines and type II pneumocytes
(45,46). These changes are observed both within and outside
the region of conformal RT (47,48), and persist up to four weeks
post irradiation in rats (49).
Detection of RILI and its severity in the RP stage, before
irreversible ﬁbrosis, could potentially alter the course of RT
fractionation and/or initiate adjuvant therapy earlier to mitigate
RILI and improve patient outcome. A number of microanatomical
and functional changes accompanying RP may be useful targets
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for hyperpolarized MRI methods. The RP phase is marked by loss
of alveolar function due to ﬂooding (i.e. edema) from epithelial
damage, thickening of alveolar and capillary walls and
inactivation of surfactant leading to reductions in ventilation
and perfusion, ultimately leading to hypoxia/ischemia, compro-
mised gas exchange and reduced lung compliance (50). ADC of
hyperpolarized 129Xe MRI may be employed to detect the
reduction of alveolar air space associated with RP, while
measurement of the time for 129Xe to diffuse through the
alveolar wall can enable the detection of the thickening of
alveolar walls due to RP.
From the metabolic standpoint, hypoxia in lung tissue plays a
role in mediation of the inﬂammatory process in RP (51).
Decreased arterial partial pressure of oxygen (paO2), an indicator
of hypoxia (52), has been reported following RT (53,4). Recent
observations from lung cancer patients post irradiation suggest
a strong correlation between dynamic changes in serum markers
(i.e. cluster of differentiation 35) and onset of RP (54), and
between the amount of exhaled nitric oxide (NO) and onset of
RP (55). Hypoxia during RP is expected to increase the level of
anaerobic glycolysis to meet the constant energy needs of the
lung tissue, which in turn leads to a higher level of lactate.
Therefore, MRI using hyperpolarized [1-13C]pyruvate and [1-13C]
lactate may be particularly sensitive to RP.
APPLICATIONOFHYPERPOLARIZEDMRI TO RILI
Hyperpolarized noble gases for anatomical and functional
MRI of RILI
Hyperpolarized 3He gas has been used for studies of RILI, in both
clinical subjects and animal models. These include identiﬁcation
of ventilation defect progression, stasis and decline correlated
with the presence of RILI measured longitudinally (1,56,52,57)
as well as approaches to register 3He images with CT images to
enable computation of RT plans for functional lung avoidance
(58,59). However, the presumption that ventilation defects
reﬂect functional deﬁcits (i.e. non-ventilated lung) due to RILI
may not be strictly true in the presence of tumor and other
airway obstruction, commonly found in COPD, a co-morbidity
of lung cancer. In this regard, mapping of ADC may be
particularly useful for identifying microstructural changes associ-
ated with RP in ventilated lung, as alveolar gas space decreases
due to inﬂammation are opposite to the alveolar enlargement
expected in emphysema, a common component of COPD.
Decreases in 3He ADC corresponding to regions of ﬁbrosis
related to radiation exposure have been reported in a rat model
of RILI consisting of fractionated delivery of 40Gy to the right
lung (33). 3He ADC mapping has also been conducted in lung
cancer patient populations (1).
While the scarcity of 3He will likely limit its wide-spread clinical
application, 129Xe is more abundant and less expensive and has
the additional advantage of relatively high tissue solubility
permitting mapping of gas exchange and perfusion. Although
129Xe development has lagged in comparison to 3He, recent
technical advances signiﬁcantly improving the achievable levels
of polarization in clinically relevant quantities (60,61) have
renewed interest in 129Xe for lung imaging, speciﬁcally mapping
of microanatomical changes using ADC, as well as imaging of gas
exchange. With a self-diffusion coefﬁcient approximately one-
tenth that of 3He, 129Xe gas provides diffusion length scales that
better match the alveolar size (~100–300 μm) at the diffusion
times (several milliseconds) typical of clinical MRI systems, and
therefore may be preferable for measurement of alveolar
damage due to RILI.
Microanatomical MRI of RP: 129Xe ADC mapping and morphometry
In our laboratory, we have developed a model of RP using
thoracic irradiation of the rat lung. This animal model permits
the design of cohort studies to look at the longitudinal effects
of RP in a controlled setting particularly the early RP stage
(typically at 2 weeks and 6weeks post-irradiation), which is
not generally possible in a human population, where RP can
remain undetectable using standard techniques (described
above). In our set-up, Sprague Dawley rats receive thoracic
irradiation using a 60Co source with an average dose rate of
2 Gy/min for a total dose of 14 Gy (62). Age-matched Sprague
Dawley rats that are not exposed to radiation serve as healthy
controls. Following imaging, the lungs are ﬁxed by intratracheal
infusion of 8mL of 10% neutral-buffered formalin and allowed
a ﬁxation period of at least 24 h. The ﬁxed lung specimens are
then embedded in parafﬁn wax, cut into 5 μm thick tissue
sections and stained with hematoxylin and eosin. Figure 2
shows representative sections of a healthy rat lung and a rat
lung 2weeks post irradiation.
For ADC mapping, a two-dimensional diffusion-weighted fast
gradient echo is typically employed (35) with sufﬁcient
diffusion time (a few milliseconds) to ensure diffusion lengths
are matched to alveolar dimensions. A single diffusion gradient
sensitization (i.e. b-value) is chosen to achieve adequate
contrast (typically 10–20 s/cm2); however, a range of b-values
can also be applied to investigate diffusional anisotropy.
Diffusion in the terminal airways of the lung can be described
by two anisotropic diffusion coefﬁcients: (i) the longitudinal
diffusion coefﬁcient (DL), describing diffusion along the length
of the airway, and (ii) the transverse diffusion coefﬁcient (DT),
describing diffusion perpendicular to the length of the airway
(63). Figure 3(a), (b) shows transverse and longitudinal views
respectively of the theoretical cylinder model, where the
Figure 1. Generalized RILI time course. Following acute radiation damage,
the injury consists of two distinct phases: (i) an early phase consisting of
cytokine induction leading to inﬂammation and hypoxia (hours to weeks)
and (ii) a later phase consisting of tissue remodeling and ﬁbrosis (months).
Hyperpolarized MRI potentially can be used detect the early phase,
particularly RP (arrow), where the effects of RILI are most likely to be
mitigated. (Figure adapted from Ghafoori et al. (8)).
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terminal airway is represented by a cylinder (inner radius r,
outer radius R) containing alveoli of size L and sleeve depth h.
Morphometric maps of the terminal airway can be computed
from DL and DT maps using the phenomenological model of
Sukstanskii and Yablonskiy (63). Figure 4 shows 2D coronal
projection xenon density images along with the corresponding
morphometric maps for r and h computed using the cylinder
model (64), for both a representative healthy rat (Fig. 4(a))
and a rat two weeks post irradiation (Fig. 4(b)). In Figure 4(a),
(b), the major airways were removed from the diffusion maps
prior to morphometric analysis. The morphometric maps show
signiﬁcant decreases in r and increases in h for the irradiated
rat compared with the healthy rat consistent with inﬂamma-
tion, whereas little difference is seen in the density-weighted
image. This suggests that underlying RP changes due to
inﬂammation are not affecting ventilation at this relatively
early stage of RILI. Based on a cohort of healthy (n = 3) and a
cohort of irradiated rats (n = 3), the mean r values decreased
from 136 (±19) μm to 102 (±30) μm (p = 0.029) respectively
and the mean h values increased from 46 (±17) μm to 71
(±27) μm (p = 0.008) respectively.
Functional MRI of RILI: dissolved-phase 129Xe MRI and measurement of
gas exchange
129Xe gas, equilibrating in the lungs, consists of a gas resonance as
well as several distinct dissolved-phase resonances, corresponding
to various tissue compartments including lung parenchyma and
red blood cells (RBCs), among others (65). Spectroscopy of 129Xe dis-
solved in lung parenchymal tissue and RBCs was ﬁrst reported by
Sakai et al. in rats (66) and Mugler et al. (67) in humans. The
application of 129Xe dissolved-phase imaging techniques to the de-
tection of RILI was ﬁrst reported by Driehuys et al. (68), where reduc-
tions in RBC image intensities were demonstrated in a rat model
three months post-irradiation using a single dose of 28Gy. The ef-
fect of xenon transfer between the gas phase and the various
dissolved-phase compartments is important for interpreting
dissolved-phase image intensity and can also provide quantitative
information concerning gas-exchange impairment with RILI.
Figure 2. Representative histological sections (40×) obtained from (a)
healthy rat lung and (b) rat lung two weeks following 14Gy irradiation.
Note the signiﬁcant thickening of the alveolar walls in (b) compared with
(a) due to inﬂammation associated with RP (shown by arrow).
Figure 3. Cylinder model of the terminal airway seen in the (a) trans-
verse view and (b) longitudinal view showing the outer airway radius
(R), inner radius (r), alveolar sleeve depth (h) and alveolar size (L). The
model is used to extract pixel-wise morphological parameters from maps
of anisotropic diffusion coefﬁcients.
Figure 4. Representative coronal 129Xe lung images and corresponding morphometry (r, h) maps for (a) healthy rat lungs and (b) rat lungs two weeks
following irradiation. Note that the 129Xe images show relatively little difference between (a) and (b), whereas the morphometry is signiﬁcantly different.
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Several dynamic 129Xe spectroscopic approaches have been
developed, in both humans and animals, based on xenon
transfer between the gas phase and the dissolved phases,
including chemically selective saturation recovery (CSSR) (69),
xenon transfer contrast (XTC) (70), xenon alveolar capillary
transfer (32), multiple exchange time xenon polarization transfer
contrast (71) and, more recently, the model of xenon transfer
exchange (72,73). The application of 129Xe XTC imaging tech-
niques to the detection of RILI was ﬁrst reported by Ruppert
et al. (74), where reductions in XTC signal were reported at four
months post irradiation in a rabbit model of RILI involving three
fractions of 20 Gy delivered to the right lung. In that work, it was
suggested that this was a reﬂection of reduced gas exchange,
consistent with blood vessel damage conﬁrmed histologically.
In contrast to XTC, CSSR resolves the tissue and RBC dissolved
phases directly as a function of a characteristic delay time τ,
allowing measurement of compartment-speciﬁc gas transfer
time constants TTr_tissue and TTr_RBC, which may each be differen-
tially sensitive to gas exchange and perfusion. Figure 5 shows a
representative set of CSSR data we have obtained from the lungs
of a healthy rat for both the tissue and the RBC compartments as
well as the gas-phase resonance for comparison. Theoretical
models of xenon exchange measured with CSSR have been
explored in humans (75) and rat models of inﬂammation using
lipopolysaccharide (24) and bleomycin (32). Xenon diffusing
capacity analogous to the diffusing capacity of carbon monoxide
can also be measured using CSSR, and has been explored for
assessment of inﬂammation due to fungal infection (25).
Our laboratory has used dynamic CSSR spectroscopy to
investigate RP in the 60Co irradiation rat model described above,
at two and six weeks post-irradiation (76). Figure 6 shows
representative CSSR curves obtained from a representative
healthy rat (Fig. 6(a)) and a two-week irradiated rat (Fig. 6(b))
(76). The solid curves are the best ﬁt to the data using the theo-
retical model of Mansson et al. (24), yielding whole-lung esti-
mates of TTr_tissue and TTr_RBC. Figure 7(a) presents the mean
transfer times obtained for the age-matched healthy cohort as
well as the irradiated cohorts at two weeks and six weeks post
irradiation. Post hoc t-tests revealed that TTr_tissue in the two-
week group was statistically signiﬁcantly elevated compared
with the healthy and six-week groups (p< 0.05) (76). This
increase in transfer time was attributed to gas exchange
reductions caused by alveolar gas barrier thickening, a conse-
quence of inﬂammation in RP. These increases in gas transfer
times were also shown to be consistent with paO2 reductions
(Fig. 7(b)) and alveolar gas barrier thickening (Fig. 2(b)) and/or
surface to volume ratio reductions measured using blood gas
analysis and histology respectively in other cohorts similarly
irradiated (76). It is likely that such whole-lung estimates of gas
exchange will beneﬁt in the future from the ability to spatially
resolve changes that may be occurring regionally in the lung.
Hyperpolarized 13C for metabolic MRI of RILI
To our knowledge, the ﬁrst use of hyperpolarized 13C in the lung
was undertaken by Ishii et al., where 13C-enriched hydro-
xyethylpropionate was used to image pulmonary blood ﬂow in
the lungs of a healthy pig (77). For metabolic imaging, the
pyruvate molecule enriched with 13C at the C-1 position can be
polarized to a high degree and the conversions of [1-13C]pyruvate
to its metabolic products, [1-13C]lactate, 13C-bicarbonate and
[1-13C]alanine, have been observed in vivo for detection of cancer
in animal models (40,78), and humans (79). Speciﬁcally, the ratio
of [1-13C]lactate signal to [1-13C]pyruvate signal (lac/pyr) has been
shown to reﬂect the presence of anaerobic glycolysis in tumors, a
surrogate for hypoxia (79). [1-13C]pyruvate has also been used to
detect reductions in reactive oxygen species following irradiation
of anaplastic thyroid carcinoma xenografts in mice (80).
Although the application of hyperpolarized [1-13C]pyruvate
imaging to the lung presents signiﬁcant challenges mainly due
to the low tissue concentrations afforded by intravenous
injection, [1-13C]lactate labeling following injection of [1-13C]py-
ruvate has been used to investigate lung ischemia in the isolated
perfused rat lung ex vivo (81). The ex vivo perfused organ
Figure 5. Hyperpolarized CSSR spectra as a function of τ from a healthy
rat lung showing gas peaks (right) as well as two dissolved-phase peaks
(left) corresponding to the RBC and lung tissue compartments respectively.
Figure 6. Representative CSSR 129Xe signals as a function of τ for lung tissue (199ppm) and RBCs (212ppm) in (a) a healthy rat and (b) an irradiated rat two
weeks post irradiation. The points represent the measured data and the lines represent the best ﬁt to the data based on the model of Mansson et al. (24).
HYPERPOLARIZED MRI OF LUNG INJURY
NMR Biomed. 2014; 27: 1515–1524 Copyright © 2014 John Wiley & Sons, Ltd. wileyonlinelibrary.com/journal/nbm
1519
approach is a useful model system to investigate the time course
of hyperpolarized [1-13C]pyruvate and its products in the lung
with the opportunity to manipulate the metabolic environment
(e.g. hypoxia) in a controlled way. In that work, a several-fold
increase in lactate labeling was observed during conditions of
ischemia compared with the base-line (i.e. normoxic) state. This
increase in lactate labeling was seen to revert to baseline upon
reperfusion and was consistent with changes in high-energy
phosphate metabolism measured using 31P NMR (81).
The ﬁrst in vivo hyperpolarized 13C-pyruvate investigation of
the lung, and of RILI, was reported by Thind et al. (62). In that
work, lac/pyr was observed to increase by 110% (p< 0.01), 57%
(p< 0.02) and 107% (p< 0.01) respectively in the entire thorax,
lung and heart tissues of rats two weeks post whole-thorax
irradiation (14Gy, as described above) compared with healthy
age-matched rats. This was consistent with RP conﬁrmed using
cell micrographs of bronchioalveolar lavage specimens and
decreases in arterial oxygen partial pressure (paO2), indicative
of hypoxia. This was not seen in tissues outside the ﬁeld of
irradiation (i.e. kidneys), nor were changes reported in blood lac-
tate levels, conﬁrming the injury was conﬁned to the thorax (62).
More recently, our group has used hyperpolarized [1-13C]pyru-
vate to investigate the regional and longitudinal metabolic effects
of RILI using an in vivo model of RILI involving conformal
irradiation of the rat (82). In this study, the right medial lobe of
the lungs of 12 Sprague Dawley rats were irradiated in two
fractions with a total dose of 18.5Gy using a modiﬁed μCT/RT
system (83). Fluoroscopy was employed to set the irradiation ﬁeld
to completely shield the beating heart. 13C-labelled pyruvic acid
was hyperpolarized using a commercial DNP system (HyperSense,
Oxford Instruments) and chemical shift imaging (CSI) performed
at 3T (GEHC Discovery MR750, Waukesha, WI) following tail vein
injection (62). Regional lactate and pyruvate data were acquired
from three irradiated and three age-matched healthy rats at 5,
10, 15 and 25days post-RT. Arterial blood was collected from each
animal prior to the [1-13C]pyruvate injection and was analyzed for
blood lactate concentration and arterial oxygen concentration
(paO2). Macrophage count was computed from histology of all
rat lungs. Figure 8 shows the slab localized in the rat as a
transverse plane encoded with CSI voxels overlaid on a standard
proton T1-weighted image. Four voxels were selected from the left
lung, right lung and heart regions from each animal and were
analyzed for lac/pyr. Arterial blood was collected from each animal
prior to the pyruvate injection and was analyzed for blood lactate
concentration and arterial oxygen concentration (paO2). Following
imaging, the rat lungs were removed, ﬁxed, sectioned and stained
for histological analysis.
Figure 9 shows the corresponding lac/pyr values for the right
lung and heart regions shown in Figure 8 at all time points.
Statistically signiﬁcant increases in lac/pyr (p< 0.05) in the
irradiated (right) lung were observed compared with healthy rats
at days 5, 10, 15 and 25-post irradiation (82). No increase in
lac/pyr was observed in the hearts of the irradiated cohort
compared with the hearts of the healthy cohorts. Neither blood
lactate concentration nor paO2 showed a signiﬁcant change
between the irradiated and the healthy cohorts. Macrophage
counts in both right and left lung were elevated for the
irradiated cohort compared with the healthy cohort (82),
consistent with the RP inﬂammatory phase of early RILI (84).
Interestingly, a signiﬁcant increase in lac/pyr was observed in
both the right and left lungs of the irradiated cohort compared
with the healthy cohort for all time points. Macrophage counts
from the right and left lungs of both the healthy rats and the
irradiated rats appeared to be highly correlated to the lac/pyr
values at all time points, with a Spearman correlation coefﬁcient
of 0.86 (p< 0.01) for the right lung and 0.85 (p< 0.01) for the left
lung (Fig. 10). No statistically signiﬁcant changes were observed
in lac/pyr in the heart or in blood lactate levels or paO2 between
healthy and irradiated animals at any time point. Furthermore,
Figure 7. (a) Mean TTr values for lung tissue and RBCs measured in a
healthy rat cohort and an irradiated rat cohort two and six weeks follow-
ing irradiation. (b) Corresponding mean arterial blood oxygen partial
pressure measured in similar cohorts. A statistically signiﬁcant increase
in TTr (* p< 0.05) was seen for lung tissue in the irradiated cohort at
two weeks compared with the healthy cohort, consistent with arterial
blood oxygenation changes.
Figure 8. 13C MR spectroscopic imaging voxels overlaid on T1-weighted
1H axial image. The lung boundary is clearly visualized as a signal void.
13C lac/pyr measurements were taken in 12 voxels, four each from the left
lung (LL), right lung (RL) and heart (H) regions as indicated. Figure
reprinted from Reference 86 with permission from Elsevier.
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no histological evidence of inﬂammation was observed in the
heart at days 10 and 15 post RT. The absence of changes in
blood lactate and paO2 levels as well as the absence of changes
in lac/pyr and histology in the heart conﬁrms that the response
to injury was conﬁned to the lung. The reduction in lac/pyr at
day 25 suggests that inﬂammation may have started to subside
at this time point (82).
DISCUSSION AND FUTURE DIRECTIONS
RILI is an important limiting factor in the RT treatment of thoracic
cancers, most notably NSCLC, responsible for 80% of lung
cancer. Strategies to mitigate RILI, which subsequently results
in irreversible ﬁbrosis, may beneﬁt from early detection of RP,
where the effects are most readily treated. MRI with
hyperpolarized nuclei, speciﬁcally following inhalation of 129Xe
and injection of [1-13C]pyruvate, may offer a useful approach
for detection of RP. To the extent that these hyperpolarized
nuclei can be delivered to the injured portions of the lung, these
approaches can offer valuable insight into the microanatomical,
functional and metabolic changes accompanying RILI. Irradiation
of animal (i.e. rodent) lungs, both whole-thorax as well as
conformal delivery, can be useful for imaging RILI in a controlled
fashion, particularly to study longitudinal effects and correlate
with histological changes.
MRI of the apparent diffusion of hyperpolarized noble gases is
a powerful tool for quantifying regional microanatomical
changes associated with RILI. For the diffusion times and gas
mixtures typically used in hyperpolarized 129Xe MRI, the diffusion
lengths are ideally suited for probing changes in the morphom-
etry of the terminal airways and alveoli associated with RILI. In
particular, alveolar size and internal radius of the terminal airway
are observed to decrease and alveolar sleeve depth is observed
to increase due to inﬂammation associated with RP. These
changes are qualitatively consistent with histology and will be
reported in detail in a future publication. The use of morphome-
try to investigate longitudinal changes, especially from confor-
mal irradiation and fractionated delivery similar to that used
clinically, and correlation with quantitative histology, will likely
be fruitful areas of future research. MRI morphometry is also
expected to beneﬁt from emerging 3D histology approaches in
order to validate microanatomical changes which are inherently
3D in nature.
The dual capability of hyperpolarized 129Xe to probe
functional as well as anatomical changes associated with RILI is
expected to be particularly beneﬁcial for detection of RP, since
functional deﬁcits (e.g. gas exchange and perfusion) are
expected to precede morphological changes. The ability to
resolve 129Xe dissolved in both the lung tissue compartment
and blood compartment (i.e. RBCs) and measure the relative
dynamics of the 129Xe signal from these compartments,
particularly following selective RF pulse strategies (e.g. CSSR),
allows measurement of gas exchange reductions associated with
RP inﬂammation as early as two weeks. The use of the 129Xe RBC
signal as an indication of blood vessel destruction expected to
accompany early radiation damage could provide valuable
mechanistic insight. Figure 6 suggests that decreases in the ratio
of 129Xe signal from the RBC phase relative to the tissue phase
may occur, possibly associated with gas exchange impairment
and/or loss of vasculature. Further work is needed in order to
delineate the interplay of these mechanistic processes and this
will likely be aided by the use of more sophisticated animal
experiments, higher nuclear polarizations and spectroscopic
imaging techniques (e.g. Dixon-based techniques). For example,
the effects of total dose, conformation, dose rate and fractionation
Figure 9. Mean (±1 standard deviation) lac/pyr measured for the right
lung, left lung and heart regions in the healthy and irradiated cohorts
at four time points (5, 10, 15 and 25 days) following irradiation. Statisti-
cally signiﬁcant increases in lac/pyr (** p< 0.01, * p< 0.05) are apparent
in the right lung and left lung of the irradiated cohort compared with the
right lung and left lung of the healthy cohort or the heart region at all
time points post irradiation. Figure reprinted from Reference 86 with per-
mission from Elsevier.
Figure 10. Scatter plots of lac/pyr versus macrophage count obtained by histology in right lung (on left) and left lung (on right) for the healthy rat
cohort and the irradiated rat cohort, showing strong correlation in both the right lung (r=0.86, p< 0.01) and the left lung (r=0.85, p< 0.01) respec-
tively. Figure reprinted from Reference 86 with permission from Elsevier.
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scheme could be studied. The data could be collected for a longer
time span (e.g. zero days to 20weeks post irradiation procedure) to
understand the effects of the underlying injury on gas exchange.
Animal studies should also advance our understanding of the
metabolic changes associated with RILI, speciﬁcally the origin of
the [1-13C]lactate changes. This would include correlation of
lac/pyr ratio and identiﬁcation of the type of proliferating leuko-
cyte. Comparison of lac/pyr data with histology following
hypoxia staining as well as leukocyte counting could help
decode the origin of lac/pyr changes in RP. Additional studies
could be performed to proﬁle the inﬂammatory cytokines, other
leukocytes (e.g. neutrophils), type II pneumocytes, endothelial
cells and ﬁbroblasts in a similar manner to test the relationship
between lac/pyr and the evolution of these physiological param-
eters as a function of time and following administration of
radioprotector chemical species such as superoxide dismutase
post-irradiation (49). The role of the contralateral lung in RILI
response is also worthy of further investigation.
Though the application of hyperpolarized MRI is well devel-
oped in animal models, particularly [1-13C]pyruvate, clinical
studies are lagging mainly due to the limited output and
availability of this technology. This is expected to change with
the emergence of turn-key polarizers capable of providing the
necessary volumes, polarizations and quality suitable for human
use. The clinical translation of these methods is unclear, but
integration of hyperpolarized MRI into the therapy plan would
likely be most useful prior to and within the ﬁrst few weeks of
RT delivery. Detection of early RP using hyperpolarized [1-13C]py-
ruvate MRI could allow monitoring of ongoing radiation therapy
of breast cancer, lung cancer and other thoracic cancers that
may be susceptible to RILI. The information could be used as
feedback for modiﬁcation of the radiation therapy (or chemo-
therapy) plan or to determine whether anti-inﬂammatory drugs
would help (e.g. corticosteroids). Since every patient may have
a slightly different physiological make-up, [1-13C]pyruvate MRI
could assist with personalized treatment, where the metabolism
of each patient could be recorded and used in the ongoing
therapeutic intervention. The non-ionizing nature of MRI also
permits repeated scans for continuous monitoring of a patient,
which may not be possible with PET or CT. Continuous monitor-
ing may be important to track the evolution of both the tumor
response and RP in cancer patients. While onset of RP leads to
higher lac/pyr post radiation therapy in the non-cancerous
injured lung, lung cancer cells may begin to demonstrate lower
lac/pyr post therapeutic intervention, as demonstrated in the
literature with other cancer cell lines (85). In addition,
hyperpolarized 13C-bicarbonate might also be useful to map
pH of tumors undergoing radiation therapy, as pH plays a vital
role in tumor progression and therapy (86).
In summary, hyperpolarized MRI techniques, most notably
129Xe gas and [1-13C]pyruvate, are very promising approaches
for detection of anatomical, functional and metabolic changes
associated with RILI. Early and regional detection of RP
associated with RILI using these emerging imaging techniques
may play a signiﬁcant role in the personalization of ongoing RT
and adjuvant therapy, thereby improving outcomes.
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